Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$17.36
-0.1%
$20.57
$16.96
$48.25
$1.46B2.161.51 million shs924,916 shs
LivaNova PLC stock logo
LIVN
LivaNova
$55.94
+1.7%
$53.92
$42.75
$59.86
$2.97B0.89519,996 shs977,319 shs
Masimo Co. stock logo
MASI
Masimo
$135.92
-0.8%
$135.72
$75.22
$195.82
$7.25B0.97394,360 shs232,180 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
-0.06%-0.52%-15.11%-25.49%-52.35%
LivaNova PLC stock logo
LIVN
LivaNova
+1.67%+7.85%+2.79%+12.01%+16.69%
Masimo Co. stock logo
MASI
Masimo
-0.75%-0.51%-2.52%+9.32%-28.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InMode Ltd. stock logo
INMD
InMode
3.471 of 5 stars
3.23.00.00.03.51.72.5
LivaNova PLC stock logo
LIVN
LivaNova
1.5773 of 5 stars
2.23.00.00.01.71.71.9
Masimo Co. stock logo
MASI
Masimo
3.9935 of 5 stars
2.23.00.04.22.11.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8088.94% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$64.4015.12% Upside
Masimo Co. stock logo
MASI
Masimo
2.43
Hold$137.431.11% Upside

Current Analyst Ratings

Latest MASI, LIVN, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$148.00 ➝ $170.00
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
4/9/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$125.00 ➝ $148.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$145.00 ➝ $166.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$117.00 ➝ $160.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/26/2024
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $117.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMode Ltd. stock logo
INMD
InMode
$492.05M2.96$2.21 per share7.85$6.68 per share2.60
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.62$4.38 per share12.78$23.72 per share2.36
Masimo Co. stock logo
MASI
Masimo
$2.05B3.51$5.72 per share23.76$25.79 per share5.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.307.557.89N/A40.22%29.80%27.02%5/2/2024 (Confirmed)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M$0.32174.8216.70N/A1.53%12.23%6.47%5/1/2024 (Confirmed)
Masimo Co. stock logo
MASI
Masimo
$81.50M$1.5190.0135.58N/A3.98%13.77%5.98%5/7/2024 (Confirmed)

Latest MASI, LIVN, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Masimo Co. stock logo
MASI
Masimo
$0.71N/A-$0.71N/AN/AN/A  
5/2/2024N/A
InMode Ltd. stock logo
INMD
InMode
$0.40N/A-$0.40N/AN/AN/A  
5/1/2024N/A
LivaNova PLC stock logo
LIVN
LivaNova
$0.47N/A-$0.47N/AN/AN/A  
2/27/2024Q4 2023
Masimo Co. stock logo
MASI
Masimo
$0.82$1.25+$0.43$1.87$545.69 million$548.90 million    
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMode Ltd. stock logo
INMD
InMode
N/A
12.51
11.87
LivaNova PLC stock logo
LIVN
LivaNova
0.44
2.95
2.51
Masimo Co. stock logo
MASI
Masimo
0.64
2.18
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
InMode Ltd. stock logo
INMD
InMode
68.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Masimo Co. stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
InMode Ltd. stock logo
INMD
InMode
6.92%
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Masimo Co. stock logo
MASI
Masimo
9.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90053.96 million53.85 millionOptionable
Masimo Co. stock logo
MASI
Masimo
5,20052.91 million47.78 millionOptionable

MASI, LIVN, and INMD Headlines

SourceHeadline
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
investorplace.com - April 25 at 6:00 AM
Specifi partners with Masimo’s audio brandsSpecifi partners with Masimo’s audio brands
installation-international.com - April 24 at 4:51 PM
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
businesswire.com - April 23 at 8:00 AM
Masimo (NASDAQ:MASI) Updates FY 2024 Earnings GuidanceMasimo (NASDAQ:MASI) Updates FY 2024 Earnings Guidance
americanbankingnews.com - April 22 at 7:36 AM
Apple Watch Series 9 Hits All-Time Low Special Offer PriceApple Watch Series 9 Hits All-Time Low Special Offer Price
forbes.com - April 22 at 12:23 AM
6 Reasons Cracker Barrel Is Struggling6 Reasons Cracker Barrel Is Struggling
msn.com - April 21 at 7:23 PM
Kornitzer Capital Management Inc. KS Invests $6.21 Million in Masimo Co. (NASDAQ:MASI)Kornitzer Capital Management Inc. KS Invests $6.21 Million in Masimo Co. (NASDAQ:MASI)
marketbeat.com - April 21 at 8:14 AM
Sumitomo Mitsui Trust Holdings Inc. Has $48.50 Million Stake in Masimo Co. (NASDAQ:MASI)Sumitomo Mitsui Trust Holdings Inc. Has $48.50 Million Stake in Masimo Co. (NASDAQ:MASI)
marketbeat.com - April 20 at 5:41 AM
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
zacks.com - April 19 at 1:15 PM
Reasons Why You Should Retain Masimo (MASI) Stock for NowReasons Why You Should Retain Masimo (MASI) Stock for Now
zacks.com - April 19 at 12:47 PM
Readystate Asset Management LP Makes New $3.22 Million Investment in Masimo Co. (NASDAQ:MASI)Readystate Asset Management LP Makes New $3.22 Million Investment in Masimo Co. (NASDAQ:MASI)
marketbeat.com - April 17 at 10:38 PM
Masimo (NASDAQ:MASI) Updates Q1 2024 Earnings GuidanceMasimo (NASDAQ:MASI) Updates Q1 2024 Earnings Guidance
marketbeat.com - April 17 at 3:42 PM
Masimo (MASI) Gains Nearly 18% YTD: Whats Driving the Rally?Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
finance.yahoo.com - April 17 at 9:25 AM
Masimo (MASI) Gains Nearly 18% YTD: Whats Driving the Rally?Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
zacks.com - April 17 at 8:46 AM
Masimo (NASDAQ:MASI) Shares Gap Up to $137.92Masimo (NASDAQ:MASI) Shares Gap Up to $137.92
americanbankingnews.com - April 17 at 5:14 AM
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in ChileMasimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
businesswire.com - April 16 at 8:00 AM
Masimo (NASDAQ:MASI) Upgraded to Buy at Stifel NicolausMasimo (NASDAQ:MASI) Upgraded to Buy at Stifel Nicolaus
americanbankingnews.com - April 16 at 4:46 AM
Stifel Upgrades Masimo (MASI)Stifel Upgrades Masimo (MASI)
msn.com - April 16 at 12:28 AM
Buy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal GrowthBuy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal Growth
markets.businessinsider.com - April 15 at 2:26 PM
Forecasting The Future: 6 Analyst Projections For MasimoForecasting The Future: 6 Analyst Projections For Masimo
markets.businessinsider.com - April 15 at 2:26 PM
Masimo (NASDAQ:MASI) Stock Rating Upgraded by Stifel NicolausMasimo (NASDAQ:MASI) Stock Rating Upgraded by Stifel Nicolaus
marketbeat.com - April 15 at 8:16 AM
Is There An Opportunity With Masimo Corporations (NASDAQ:MASI) 24% Undervaluation?Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?
finance.yahoo.com - April 14 at 12:30 PM
Arrogant Apple Goes ‘Ape Shit’ Over Watch Ban, With 900+ With Appeal Document That Spews Out Wild Claims Against Masimo & SonosArrogant Apple Goes ‘Ape Shit’ Over Watch Ban, With 900+ With Appeal Document That Spews Out Wild Claims Against Masimo & Sonos
channelnews.com.au - April 10 at 8:36 PM
Masimo To Explore Spin-Off Of Its Consumer UnitMasimo To Explore Spin-Off Of Its Consumer Unit
forbes.com - April 10 at 3:35 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Masimo logo

Masimo

NASDAQ:MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.